GlassScriptPhysician profile
Bryan T Smedley
NPI 1275822926
$2,737.46
in general payments reported to CMS, 2019-2025
14 companies · $839 in 2025
The $839 reported for 2025 was more than what 77% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $116 · 2021: $331 · 2022: $313 · 2023: $203 · 2024: $597 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Consulting Fee: $79.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.10 |
| Consulting Fee | $79.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $613.24 | 2020-2025 | |
| Glaxosmithkline, LLC. | $541.66 | 2021-2025 | Nucala |
| Stryker Corporation | $496.14 | 2019-2025 | Scopis Ent, Clarifix Cryotherapy Device, Audion Et Dilation System |
| Optinose US, INC. | $315.58 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $173.74 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $160.10 | 2019-2025 | |
| Neurent Medical Limited | $108.06 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Novartis Pharmaceuticals Corporation | $83.04 | 2021-2022 | |
| Smith+Nephew, INC. | $58.67 | 2019-2023 | Halo, Tula |
| Intersect Ent, INC. | $56.69 | 2019-2021 | |
| Baxter Healthcare | $48.00 | 2024 | Perclot |
| Alk-Abello, INC | $44.98 | 2021-2022 | |
| Arrinex, INC. | $21.15 | 2019 | |
| Phadia US INC. | $16.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Smedley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.